Kinnate Biopharma Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2020 to Q4 2023
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Kinnate Biopharma Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2020 to Q4 2023.
- Kinnate Biopharma Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2023 was 46.6M shares, a 5.7% increase year-over-year.
- Kinnate Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 46.6M shares, a 5.7% increase from 2022.
- Kinnate Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 44.1M shares, a 1.07% increase from 2021.
- Kinnate Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 43.6M shares, a 544% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)